Journal article
Efficacy and tolerability of ADHD medications in a clinical practice
Journal of pediatric neurology, v 6(1), pp 005-010
Mar 2008
Featured in Collection : UN Sustainable Development Goals @ Drexel
Abstract
Abstract
Randomized controlled trials have shown that stimulants reduce symptoms of impulsivity and hyperactivity in children with attention deficit/hyperactivity disorder (ADHD); however, these rigid protocols show no advantage of one medication over another. Our study examined the question of differential efficacy and tolerability of five medications used for ADHD, in the open-label setting of our outpatient child neurology clinic. This retrospective study identified 137 children and adolescents (109 boys and 28 girls), with a mean age of 10 years (range 4 to 19 years) treated for ADHD. Treatment options were amphetamine/dextroamphetamine extended release (adderall XR) in 19.0%, amphetamine/dextroamphetamine (adderall), osmotic controlled-released (OROS) formulation of methylphenidate (OROS-MPH, concerta) in 29.2%, atomoxetine (strattera) in 21.9% and methylphenidate standard release (MPH) in 16.8%. Global effectiveness was assessed for each medication. Overall, 78% of patients improved with medication, with no significant statistical difference in efficacy among the five medications. Side effects included decreased appetite (14.6%), insomnia (10.2%), headaches (7.3%), and tics (3.7%). The only difference in side effects was with atomoxetine showing a significantly lower incidence of headaches than amphetamine/dextroamphetamine XR, amphetamine/dextroamphetamine or OROS-MPH. In conclusion, our results in the open-label setting were comparable to those found in randomized controlled trials; the medications we examined were equally effective with minimal differences in side effect profiles.
Metrics
14 Record Views
Details
- Title
- Efficacy and tolerability of ADHD medications in a clinical practice
- Creators
- Jill W. Miller-Horn - Drexel UniversityJoseph Kaleyias - Drexel UniversityIgnacio Valencia - Drexel UniversityJoseph J. Melvin - Drexel UniversityDivya S. Khurana - Drexel UniversityH. Huntley Hardison - Drexel UniversityHarold Marks - Drexel UniversityAgustin Legido - Drexel UniversitySanjeev V. Kothare - Drexel University
- Publication Details
- Journal of pediatric neurology, v 6(1), pp 005-010
- Publisher
- Georg Thieme Verlag KG
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- Pediatrics
- Web of Science ID
- WOS:000215508200002
- Other Identifier
- 991019170448604721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Web of Science research areas
- Pediatrics